Oticon Real vs RxEars Rxi

The Oticon Real is a premium prescription behind-the-ear hearing aid released in 2023, priced at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.7/5, placing it in the top 10% of the 39 prescription hearing aids tested and ranking #5 in its category. Speech performance is a clear strength for the Oticon Real. Speech in quiet scored a strong 4.0/5, sitting 0.64 points above the category average. Speech in noise measured 2.9/5—above the category average by 0.82 points, though still mixed in absolute terms. This combination makes it a solid choice for listeners prioritizing conversation clarity across different environments. Feedback handling scored a strong 4.0/5 in absolute terms, though this falls 0.72 points below the category average of 4.72/5. Own voice comfort scored 2.4/5, which is 0.30 points below the category average—a potential consideration for those sensitive to how their own voice sounds. Music streaming performance was mixed at 2.8/5, essentially matching the category average. The Oticon Real is a two-time Expert's Choice Award winner (2023, 2024) and offers flexible power options with both rechargeable and disposable batteries. It supports iPhone and Android streaming along with hands-free calling. Within its premium price tier, it faces strong competition from devices like the Phonak Sphere Infinio and Oticon Intent, but remains a compelling option for users who prioritize speech intelligibility and are willing to invest in top-tier technology.

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it ranks #24 of 39 prescription hearing aids tested, placing it in the top 59% of its category. This device demonstrates notable strengths in speech understanding in quiet environments, scoring 4.3/5—a strong result that sits 0.89 points above the category average of 3.40/5. Feedback handling is excellent at 4.7/5, providing stable performance during movement without the whistling that can plague some hearing aids. Speech in noise performance is mixed at 2.1/5, essentially matching the category average. The RxEars Rxi has significant limitations to consider. Own-voice comfort scores low at 1.6/5, falling 1.10 points below the category average—users may notice their own voice sounds unnatural or boomy. Music streaming is not supported, scoring 0.0/5, which is 2.76 points below the category average. This device uses disposable batteries rather than rechargeables. The RxEars Rxi is best suited for users who prioritize discreet cosmetics and clear speech understanding in quieter settings, and who don't need music streaming capabilities. Those sensitive to own-voice quality or who frequently listen to streamed audio should explore alternatives.